Shipment of R21 malaria vaccine to Central African Republic marks latest milestone for child survival

Published on June 6, 2024

Last month, UNICEF delivered over 43,200 doses of the R21/Matrix-M malaria vaccine developed through collaboration between Oxford University’s Jenner Institute and Serum Institute of India leveraging by Novavax’s saponin-based adjuvant technology, by air to Bangui, Central African Republic, with further shipment of about 163,800 doses to follow, which is allocated for children in the CAR currently.
Continue reading on website
Other news

Oxford University Innovation announces new Chief Executive

June 5, 2024
Oxford University Innovation (OUI) today announces the permanent appointment of Chief Executive Officer Dr Mairi Gibbs. Mairi has a track record of more than 20 years in university technology transfer including multiple roles leading strategic business management and operational areas of OUI.

Response to 'Public Statement on Proposed Amendments to University statutes'

June 6, 2024
(previously called 'Brief on Illiberal Amendments...)